Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
SHANGHAI PECHEM
00338
5
SINOPEC CORP
00386
| (FY)Dec 31, 2025 | (Q6)Jun 30, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (FY)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|
| Turnover | 15.77%1.45B | 24.74%725.81M | 46.56%1.25B | 57.62%884.27M | --581.86M | 68.00%852.1M | --561.01M | --507.2M |
| Operating income | 15.77%1.45B | 24.74%725.81M | 46.56%1.25B | 57.62%884.27M | 581.86M | 68.00%852.1M | 561.01M | 507.2M |
| Cost of sales | -17.79%-730.06M | -26.85%-367.33M | -45.92%-619.82M | -59.11%-446.47M | ---289.57M | -60.03%-424.76M | ---280.61M | ---265.42M |
| Operating expenses | -17.79%-730.06M | -26.85%-367.33M | -45.92%-619.82M | -59.11%-446.47M | -289.57M | -60.03%-424.76M | -280.61M | -265.42M |
| Gross profit | 13.78%715.76M | 22.64%358.49M | 47.20%629.05M | 56.14%437.8M | 292.3M | 76.75%427.34M | 280.4M | 241.78M |
| Selling expenses | -16.98%-457.53M | -23.38%-224.61M | -36.88%-391.12M | -46.55%-270.5M | ---182.05M | -51.29%-285.74M | ---184.58M | ---188.87M |
| Administrative expenses | -36.55%-124.94M | -51.01%-48.52M | -119.79%-91.5M | -111.65%-58.59M | ---32.13M | -51.05%-41.63M | ---27.68M | ---27.56M |
| Research and development expenses | -18.75%-25.43M | -14.12%-10.72M | 10.21%-21.41M | -1.32%-15.86M | ---9.39M | -46.77%-23.85M | ---15.65M | ---16.25M |
| Impairment and provision | -366.67%-112K | -1,156.25%-201K | 65.22%-24K | 633.33%16K | ---16K | -1,625.00%-69K | ---3K | ---4K |
| -Other impairment is provision | -366.67%-112K | -1,156.25%-201K | 65.22%-24K | 633.33%16K | ---16K | -1,625.00%-69K | ---3K | ---4K |
| Special items of operating profit | 92.85%39.29M | 2,117.84%26.48M | 67.74%20.37M | 54.43%16.42M | --1.19M | 113.41%12.15M | --10.64M | --5.69M |
| Operating profit | 1.15%147.05M | 44.37%100.92M | 64.82%145.38M | 73.18%109.29M | 69.91M | 496.28%88.2M | 63.11M | 14.79M |
| Financing cost | 31.52%-19.64M | 4.19%-13.63M | -4.26%-28.67M | -4.55%-21.67M | ---14.22M | -1.02%-27.5M | ---20.73M | ---27.22M |
| Share of profits of associates | ---106K | ---20K | ---- | ---- | ---- | ---- | ---- | ---- |
| Earning before tax | 9.08%127.31M | 56.73%87.27M | 92.26%116.71M | 106.74%87.62M | 55.68M | 588.35%60.7M | 42.38M | -12.43M |
| Tax | -6.73%-62.11M | -40.95%-38.76M | -73.82%-58.19M | -98.96%-41.2M | ---27.5M | -280.48%-33.48M | ---20.71M | ---8.8M |
| After-tax profit from continuing operations | 11.42%65.2M | 72.14%48.51M | 114.94%58.52M | 114.17%46.42M | 28.18M | 228.24%27.22M | 21.68M | -21.23M |
| Earning after tax | 11.42%65.2M | 72.14%48.51M | 114.94%58.52M | 114.17%46.42M | 28.18M | 228.24%27.22M | 21.68M | -21.23M |
| Profit attributable to shareholders | 11.42%65.2M | 72.14%48.51M | 114.94%58.52M | 114.17%46.42M | 28.18M | 228.24%27.22M | 21.68M | -21.23M |
| Basic earnings per share | -5.56%1.02 | 1.08 | ||||||
| Diluted earnings per share | -6.48%1.01 | 1.08 | ||||||
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
| Audit Opinions | Unqualified Opinion | -- | Unqualified Opinion | -- | -- | Unqualified Opinion | -- | Unqualified Opinion |
| Auditor | KPMG | -- | KPMG | -- | -- | KPMG | -- | KPMG |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.